SCHEMBL711059

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL717265	0.86	CA2 (0.38)	ALDH1A1GLA
	SCHEMBL716410	0.86	—	—
	SCHEMBL710025	0.84	HTR1A (0.31)	—
	SCHEMBL714606	0.82	ALDH1A1 (0.33)	ALDH1A1GLA
	SCHEMBL929292	0.79	MAPK14 (0.35)	ALDH1A1
	SCHEMBL929792	0.78	ALDH1A1 (0.33)	ALDH1A1
	SCHEMBL712807	0.77	APP (0.38)	APP
	SCHEMBL713705	0.74	ALDH1A1 (0.30)	ALDH1A1GLA
	SCHEMBL712606	0.74	ALDH1A1 (0.41)	ALDH1A1GLA
	SCHEMBL8500697	0.70	GPR84 (0.33)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.